Press releases | Finanzwire

Basculer en Français

11230	Companies
249103	Keywords
177030	Articles
134933	Press releases

Home
Press releases

PRESS RELEASE

published on 10/02/2025 at 08:00, 1 year ago

Amoéba accelerates the development of Axpera: Very convincing results observed by winegrowers; An approval schedule in line with the market launch in 2026.
Amoéba to present positive results of wine-growing trials with its innovative biological solution 'AXPERA' to agricultural press, amidst changing plant health regulations in France and Europe

AMOEBA AXPERA Wine-growing Trials Biological Solution Plant Health Regulations
PRESS RELEASE

published on 10/02/2025 at 08:00, 1 year ago

CBI and Blockware Solutions strengthen their capital ties
CBI and Blockware Solutions strengthen capital ties with a partnership for U.S. market growth and CBI's increased stake in Blockware. CBI recorded a 40% ROI in August 2025 through mining activities

Partnership ROI CBI Mining Activities Blockware Solutions
PRESS RELEASE

published on 10/02/2025 at 07:30, 1 year ago

Nordex Group secures an order for 90 MW in Türkiye
Nordex Group secures 90 MW wind energy order in Türkiye from new customer ADY Akdeniz Rüzgar Enerjisi Üretim A.Ş. for R24-Gürün project. Project to further Türkiye's energy transition

Nordex Group Türkiye Wind Energy 90 MW ADY Akdeniz
PRESS RELEASE

published on 10/02/2025 at 07:30, 1 year ago

Technip Energies Announces Publication Date for Financial Results and Conference Call for the First Nine Months of 2025
Technip Energies to release financial results for the first nine months of 2025 on Oct 30, 2025, with a conference call. Webcast available. About Technip Energies and contact details

Financial Results Conference Call Euronext Paris Webcast Technip Energies
PRESS RELEASE

published on 10/02/2025 at 07:30, 1 year ago

Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations
Nicox's NCX 470 shows sustained efficacy with no new safety concerns in Denali trial. Data presented at upcoming ophthalmology conferences

Nicox NCX 470 Denali Trial Ophthalmology Conferences Sustained Efficacy
PRESS RELEASE

published on 10/02/2025 at 07:00, 1 year ago

Baloise survey: less than half of the Swiss population are in a position to save
Baloise survey reveals less than half of Swiss population save regularly, emphasizing importance of financial literacy and early pension planning

Survey Baloise Financial Literacy Swiss Population Pension Planning
PRESS RELEASE

published on 10/02/2025 at 07:00, 1 year ago

Diya Lowe takes over as Head of Distribution Asia Pacific
Diya Lowe appointed Head of Distribution Asia Pacific at Bellevue Asset Management AG, strengthening the company's presence and business development in the region

Asset Management Bellevue Asset Management AG Asia Pacific Diya Lowe Head Of Distribution
PRESS RELEASE

published on 10/02/2025 at 07:00, 1 year ago

Newron to present new analyses from and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 38th ECNP Congress 2025
Newron Pharmaceuticals to present new analyses and updates on evenamide as treatment for schizophrenia at the 38th ECNP Congress 2025

Clinical Program Schizophrenia Newron Pharmaceuticals Evenamide ECNP Congress
PRESS RELEASE

published on 10/02/2025 at 06:59, 1 year ago

grenke is on track with EUR 2.4 billion in new business
grenke AG shows strong performance with EUR 2.4 billion in leasing new business, achieving 5.8% growth year-on-year. CM2 margin in line with guidance at 16.6%

Financial Performance Business Growth Leasing GRENKE AG CM2 Margin
PRESS RELEASE

published on 10/02/2025 at 06:30, 1 year ago

Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron
Formycon secures U.S. License Date for proposed Aflibercept Biosimilar FYB203 following settlement and license agreement with Regeneron. Commercial launch expected in Q4/2026

Formycon Regeneron Valorum Biologics Aflibercept Biosimilar Patent Disputes

Accesswire

Published on 10/27/2026 at 01:00, 2 hours 1 minute ago

Mining Exploration Entity or Oil and Gas Exploration Entity Quarterly Cash Flow Report
Published on 10/27/2026 at 00:10, 2 hours 51 minutes ago

Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:30, 3 hours 31 minutes ago

Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:00, 4 hours 1 minute ago

American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 5 hours 1 minute ago

IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors

View all ACCESSWIRE

EQS Group

Published on 10/27/2026 at 01:15, 1 hour 46 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 10/27/2026 at 01:05, 1 hour 56 minutes ago

New electrification index shows China out front as US risks stalling and Europe's policies outpace delivery
Published on 10/26/2026 at 22:23, 4 hours 38 minutes ago

EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 5 hours 3 minutes ago

EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 5 hours 28 minutes ago

UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT

Les Echos

Published on 10/26/2026 at 18:11, 8 hours 50 minutes ago

Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 17:45, 9 hours 16 minutes ago

Weekly share buyback
Published on 10/26/2026 at 17:30, 9 hours 31 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2026
Published on 10/26/2026 at 07:30, 19 hours 31 minutes ago

EURAZEO’S SUPERVISORY BOARD APPOINTS CHRISTOPHE BAVIÈRE AS CHAIRMAN OF THE EXECUTIVE BOARD AND CEO
Published on 10/23/2026 at 20:33, 3 days 6 hours ago

Disclosure of transactions in own shares from October 19 to October 23, 2026

View all LES ECHOS COMFI WIRE